| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 10/02/2008 | US20080241289 Preparation and utility of non-nucleoside reverse transcriptase inhibitors |
| 10/02/2008 | CA2682016A1 Pyrazolo [1,5-a]pyrimidines as inhibitors of stearoyl-coa desaturase |
| 10/02/2008 | CA2681536A1 Pyrimido[4,5-d]azepine derivatives as 5-ht2c agonists |
| 10/02/2008 | CA2681393A1 New imidazolo-heteroaryl derivatives and biological applications thereof |
| 10/02/2008 | CA2680775A1 Aza-pyridopyrimidinone derivatives |
| 10/01/2008 | EP1975620A2 Three hybrid assay system |
| 10/01/2008 | EP1973918A2 Derivatives of beta-amino acid as dipeptidyl peptidase-iv inhibitors |
| 10/01/2008 | EP1973917A2 Protein kinase inhibitors |
| 10/01/2008 | EP1973916A1 PYRROLO Ýl,2-A¨QUINOXALINE DERIVATIVES AS ADENOSINE A3 RECEPTOR MODULATORS AND USES THEREOF |
| 10/01/2008 | EP1973915A2 Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 |
| 10/01/2008 | EP1973914A2 Transforming growth factor modulators |
| 10/01/2008 | EP1973909A2 Transforming growth factor modulators |
| 10/01/2008 | EP1973898A1 Pdf inhibitors |
| 10/01/2008 | EP1973886A2 Prokineticin 1 receptor antagonists |
| 10/01/2008 | EP1973545A2 Bicyclic heteroaryl compounds |
| 10/01/2008 | EP1713811B1 Use of phthalocyanines as marking substances for liquids |
| 10/01/2008 | EP1654239A4 Peptide deformylase inhibitors |
| 10/01/2008 | EP1622903B1 Cannabinoid receptor ligands and uses thereof |
| 10/01/2008 | EP1372655B1 Cathepsin cysteine protease inhibitors |
| 10/01/2008 | CN101277962A Bicyclic aromatic compounds useful as inhibitors of mitogen-activated protein kinase-activated protein kinase-2 |
| 10/01/2008 | CN101277961A Tetrahydro-pyrrolizinone compounds as LFA-1 mediators |
| 10/01/2008 | CN101277949A Dipeptidyl peptidase-iv inhibitors |
| 10/01/2008 | CN101277700A Pyrimidine compounds as serotonin receptor modulators |
| 10/01/2008 | CN101274935A Amino acid-containing palisade porphyrin compound, preparation thereof and application thereof |
| 10/01/2008 | CN100423202C Method for using special chelant for micro electronic |
| 10/01/2008 | CN100422186C Methanesulfonic acid salt of pyrazolopyrimidine compound, crystal thereof, and process for producing the same |
| 10/01/2008 | CN100422185C Novel derivatives of cycloalcanodiones, method for the production thereof and their pharmacological applications |
| 10/01/2008 | CN100422180C Amyloid plaque aggregation inhibitors and diagnostic imaging agents |
| 10/01/2008 | CN100422173C Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 10/01/2008 | CN100422172C Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 10/01/2008 | CN100421663C Imidazo (4,3-e)-1,2,4-triazolo(1,5-c) pyrimidines as adenosine A2A receptor antagonists |
| 09/30/2008 | US7429663 7-(Pyrimidin-4-yl)-Imidazo[1,2-a]Pyrimidin-5(1H)-ones as GSK3β inhibitors |
| 09/30/2008 | US7429658 Synthesis of protected pyrrolobenzodiazepines |
| 09/30/2008 | US7429610 diindole compounds as anticancer agents; potentiation; effective against estrogen-dependent, estrogen-independent, drug-resistant and/or metastasized cancers |
| 09/30/2008 | US7429609 Pyrazole compound and medicinal composition containing the same |
| 09/30/2008 | US7429599 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK |
| 09/30/2008 | US7429598 Spirocondensed quinazolinones and their use as phosphodiesterase inhibitors |
| 09/30/2008 | US7429597 Heterobicyclic compound such as quinazoline anticoagulants and factor X inhibitors |
| 09/30/2008 | US7429596 Oxidoreductase inhibitors; anticancer agents; antiinflammatory agents |
| 09/30/2008 | US7429594 Substituted heterocyclic compounds and methods of use |
| 09/30/2008 | US7429586 Non-imidazole aryloxyalkylamines |
| 09/30/2008 | US7429578 e.g. phenyl-3,4-dihydropyrrolo[4,3,2-de]isoquinolin-5-(1H)-one; anticarcinogenic agent; stroke, head trauma, and neurodegenerative disease; potentiating cytotoxicity of a DNA-damaging cytotoxic agent or ionizing radiation |
| 09/30/2008 | US7429574 4-heterocyclo-pyrrolo[2,3d] pyrimidine compositions and their use |
| 09/30/2008 | CA2195856C Substituted o6-benzylguanines and use thereof |
| 09/25/2008 | WO2008116064A2 Fused heterocyclic compounds useful for the treatment of proliferative, allergic, autoimmune or inflammatory diseases |
| 09/25/2008 | WO2008115381A1 Pyridazinone derivatives useful as glucan synthase inhibitors |
| 09/25/2008 | WO2008115262A2 Hsp90 inhibitors containing a zinc binding moiety |
| 09/25/2008 | WO2008114607A1 Water-soluble metal phthalocyanine complex, sensor element, sensor using the sensor element, and method for production of sensor element |
| 09/25/2008 | WO2008113711A1 Substituted pyrimidodiazepines useful as plk1 inhibitors |
| 09/25/2008 | WO2008113469A2 Substituted imidazopyrimidines and triazolopyrimidines |
| 09/25/2008 | WO2008097428A3 Compounds and compositions as modulators of gpr119 activity |
| 09/25/2008 | WO2008096360A3 Frictionless molecular rotary motors |
| 09/25/2008 | WO2008086128A3 Aminopyrazole kinase inhibitors |
| 09/25/2008 | WO2008083398A3 Intermediate useful in preparing certain pyrrolotriazine compounds and a process for making the intermediate |
| 09/25/2008 | WO2008027585A3 Pyrrolo[3,2-d]pyrimidines that are selective antagonists of a2b adenosine receptors |
| 09/25/2008 | US20080234481 Forming salts such as tartrate or mandelate ; chemical intermediate |
| 09/25/2008 | US20080234479 Dissolving in water miscible solvent; recovering by precipitation |
| 09/25/2008 | US20080234316 Quinuclidine Amide Derivatives |
| 09/25/2008 | US20080234303 Inhibitors of the FAK (focal adhesion kinase) protein tyrosine kinases, antiproliferative, antitumor; for example 5-{4-[(1-Hydroxy-cyclopentylmethyl)-amino]-5-trifluoromethyl-pyrimidin-2-ylamino}-1,3-dihydro-indol-2-one |
| 09/25/2008 | US20080234297 HSP90 Inhibitors Containing a Zinc Binding Moiety |
| 09/25/2008 | US20080234296 Triazolo[4,5-d] pyramidine derivatives and their use as purinergic receptor antagonists |
| 09/25/2008 | US20080234284 Pyrazolo[1,5-a]Pyrimidin-7-Yl Amine Derivatives as Protein Kinase Inhibitors |
| 09/25/2008 | US20080234276 Heterocyclic Triazines as Hypoxic Selective Protein Kinase Inhibitors |
| 09/25/2008 | US20080234268 Effective for prophylaxis and treatment of diseases, such as ("c-Met") hepatocyte growth factor receptor mediated diseases; N-(4-(3-amino-1H-indazol-4-yl)-3-fluorophenyl)-1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazole-4-carboxamide; treatment of neoplasia selected from lung, breast, colon cancer |
| 09/25/2008 | US20080234262 For treating Mammalian Target of Rapamycin (mTOR)-related disorders and phosphatidylinositol-3 kinase ("PI3K")-related disorders; N-{3-[1-(1-benzylpiperidin-4-yl)-4-morpholin-4-yl-1H-pyrazolo[3,4-d]pyrimidin-6-yl]phenyl}-N'-methylurea; anticarcinogenic agents, antiinflammatory agents |
| 09/25/2008 | US20080234255 Polo-like kinase inhibitor, antitumor agent, antiproliferative agent for treating breast, colon, lung and prostate tumors; 4-(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,4]diazepin-2-ylamino)-3-methoxy-benzoic acid; chemical intermediates |
| 09/25/2008 | US20080234254 anticarcinogenic agents for treating leukaemia, non-small cell lung cancers, colonic cancers, breast cancers, ovarian cancers, renal cancers and melanoma; in vivo hydrolysable ester or amide; N-(2-amino-phenyl)-4-[1-(3,4-dihydroisoquinolin-2(1H)-ylmethyl)vinyl]benzamide; solid phase synthesis |
| 09/25/2008 | US20080234252 2-[4-(4-Chlorophenyl)-5-(methoxymethyl)-4H-1,2,4-triazol-3-yl]isoindoline; vasopressin antagonists; dysmenorrhea, Alzheimer's disease, anorexia nervosa, anxiety, anxiety disorder, asthma, atherosclerosis, autism, cardiovascular disease |
| 09/25/2008 | US20080234250 Heterocyclic Condensed Compounds Useful as Antidiuretic Agents |
| 09/25/2008 | US20080233606 Use of raman spectroscopy in enzyme activity assays |
| 09/25/2008 | US20080233047 Symmetric and Asymmetric Halogen-Containing Metallocarboranylporphyrins and Uses Thereof |
| 09/25/2008 | US20080230058 Dry powder dispersing apparatus and methods for their use |
| 09/25/2008 | CA2681501A1 Pyrazolopyrimidine analogs and their use as mtor kinase and pi3 kinase inhibitors |
| 09/25/2008 | CA2680757A1 Substituted pyrimidodiazepines useful as plk1 inhibitors |
| 09/25/2008 | CA2680583A1 Pyridazinone derivatives useful as glucan synthase inhibitors |
| 09/24/2008 | EP1972631A1 Imidazopyridazines as PI3K lipid kinase inhibitors |
| 09/24/2008 | EP1972629A1 New imidazolo-heteroaryl derivatives with antibacterial properties |
| 09/24/2008 | EP1971608A1 Spiroketals |
| 09/24/2008 | EP1971599A1 Antiviral 2-carboxy-thiophene compounds |
| 09/24/2008 | EP1885725B1 Tricyclic azole derivatives, their manufacture and use as pharmaceutical agents |
| 09/24/2008 | EP1509528B1 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 09/24/2008 | EP1322650B1 Farnesyl transferase inhibiting 6-heterocyclylmethyl quinoline and quinazoline derivatives |
| 09/24/2008 | CN101273045A 7-[2-[4-(6-fluoro-3-methyl-1,2-benzisoxazol-5-yl)-1-piperazinyl]ethyl]-2-(1-propynyl)-7h-pyrazolo-[4,3-e]-[1,2,4]-triazolo-[1,5-c]-pyrimidin-5-amine |
| 09/24/2008 | CN101273044A Preparation of diazapentalene derivatives via epoxydation of dihydropyrroles |
| 09/24/2008 | CN101273043A Pyrazolo[1,5-alpha]pyrimidinyl derivatives useful as corticotropin-releasing factor (CRF) receptor antagonists |
| 09/24/2008 | CN101273042A Macrocyclic inhibitors of hepatitis C virus |
| 09/24/2008 | CN101273041A Luminescent vargula luciferin substrate and process for producing the same |
| 09/24/2008 | CN101273040A Oxadiazolyl pyrazolo-pyrimidines as MGLUR2 antagonists |
| 09/24/2008 | CN101270120A Novel tricyclic derivatives, method for preparing same and pharmaceutical compositions containing same |
| 09/24/2008 | CN100420689C Porphyrin derivate with macrosubstituent, preparation process thereof and use as small molecule antioxidant |
| 09/24/2008 | CN100420688C Pyrimido[4,5-d]pyrimidine derivatives with anticancer activity |
| 09/24/2008 | CN100420674C Process for preparing phencynonate optical isomer |
| 09/23/2008 | US7427682 Indole derivatives as selective androgen receptor modulators (SARMS) |
| 09/23/2008 | US7427681 Anticancer agents; antidiabetic agents; Alzheimer's disease |
| 09/23/2008 | US7427637 Kinesin spindle protein (KSP) inhibitors; antiproliferative and -carcinogenic agents; side effects reduction; used with an estrogen receptor modulator; e.g. bicyclic dihydropyrrole derivatives |
| 09/23/2008 | US7427630 1-{1-[1-(4-Methoxy-2-methylphenyl)-6-methyl-2,3-dihydro-1H-pyrrolo[2,3-b]pyridin-4-yl]-1H-pyrazol-3-yl}imidazolidin-2-one; potent; to treat central nervous system disorders; antidepressants; Anxiolytic agents; mood disorders; anagesics; gastrointestinal disorders like irritable bowel syndrome |
| 09/23/2008 | US7427625 Substituted thiatriazaacenaphthylene-6-carbonitrile kinase inhibitors |
| 09/23/2008 | US7427624 with improved pharmacological properties and pharmacokinetic properties, oral bioavailability, greater potency and extended effective half-life in vivo; Crohn's disease, psoriasis, rheumatoid arthritis, T-cell lymphomas, T-cell leukemia, solid tumors, transplant tissue rejection, autoimmune diseeases |
| 09/23/2008 | US7427616 e.g. 8-(1-methyl-4-phenyl-1H-imidazol-5-yl)-9H-purin-6-amine9-methyl-8-(1-methyl-4-phenyl-1H-imidazol-5-yl)-9H-purin-6-amine; Tie2 receptor tyrosine kinase and angiogenesis inhibitor; diabetic retinopathy, psoriasis, cancer, rheumatoid arthritis, atheroma, Kaposi's sarcoma and haemangioma |
| 09/23/2008 | US7427613 7-aryl-3,9-diazabicyclo(3.3.1)non-6-ene derivatives and their use as renin inhibitors in the treatment of hypertension, cardiovascular or renal diseases |